2.52
1.90%
-0.0487
Minerva Neurosciences Inc Azioni (NERV) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
17.98%
7.1719
|
6.0791 | 4.52 | 5.3485 | 5.0697 |
Depreciation and Amortization |
0.07%
0.00136
|
0.00136 | 0.00136 | 0.00136 | - |
Operating Income/Loss |
17.98%
-7.1719
|
-6.0791 | -4.52 | -5.3485 | -5.0697 |
Income/Loss From Continuing Operations Before Tax |
15.37%
-9.0225
|
-7.8204 | -6.192 | -6.9704 | -6.7261 |
Income/Loss From Continuing Operations After Tax |
15.37%
-9.0225
|
-7.8204 | -6.192 | -6.9704 | -6.7261 |
Net Income/Loss
|
15.37%
-9.0225
|
-7.8204 | -6.192 | -6.9704 | -6.7261 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
95.27%
0.3581
|
7.569 | 5.5112 | 5.3402 | -0.000001 |
Diluted Average Shares |
95.27%
0.3581
|
7.569 | 5.5112 | 5.3402 | -0.000001 |
Basic Earnings Per Share |
16.50%
-1.20
|
-1.03 | -1.12 | -1.31 | -1.26 |
Diluted Earnings Per Share |
16.50%
-1.20
|
-1.03 | -1.12 | -1.31 | -1.26 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):